Treatment Information

Back

Bladder Cancer treatment details. Chemotherapy.

Aarhus University Hospital, Aarhus, Denmark.

Survival: monthsCountry:Denmark
Toxiciy Grade:5City/State/Province:Aarhus
Treatments:ChemotherapyHospital:Aarhus University Hospital
Drugs:Journal:Link
Date:Oct 2006

Description:

Patients:
This phase II study involved 64 patients with transitional cell carcinoma of the urothelium. The median patient age was 65 years and 83% were male.

Treatment:
Patients were treated with the chemotherapy agents pemetrexed and gemcitabine.

Toxicity:
There was one treatment-related death due to infection. Grade 4 neutropenia, anemia, and shortness of breath were also reported.

Results:
The median overall survival was 10.3 months.

Support:
This study was supported by Eli Lilly, makers of gemcitabine and pemetrexed.

Correspondence: Dr. H. von der Maase; email: [email protected]



Back